{"id":"W4307230117","doi":"10.1093/rheumatology/keac605","title":"Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study","year":2022,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Discontinuation; Placebo; Adverse effect; Internal medicine; Psoriasis; Randomized controlled trial; Gastroenterology; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005513262,0.001293322,0.002152043,0.0002792807,0.0003862283,0.0007255835,0.0006531367,0.001195316,0.002980561],"category_scores_gemma":[0.00237836,0.0005297082,0.002551766,0.0003001524,0.0005921391,0.00081007,0.0005435997,0.002208138,0.0006478164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003806404,"about_ca_system_score_gemma":0.0007420396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005599834,"about_ca_topic_score_gemma":0.001598458,"domain_scores_codex":[0.9982359,0.001002188,0.0001264061,0.0001759375,0.0003116241,0.00014786],"domain_scores_gemma":[0.9974916,0.0005820039,0.0009623982,0.0002929736,0.0002179316,0.0004530862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8719776,0.0190003,0.0219105,0.001152341,0.004737913,0.0002710802,0.0003013318,0.001556394,0.02462402,0.0001029461,0.00407439,0.05029118],"study_design_scores_gemma":[0.492453,0.3404512,0.151435,0.0001671101,0.004062047,0.0005484692,0.0001071654,0.001428853,0.005381595,0.0001296952,0.003726197,0.0001098028],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908997,0.004073677,0.0004024265,0.0003332953,0.00008486216,0.0006775968,0.001669606,0.0000509835,0.001807919],"genre_scores_gemma":[0.9904571,0.001448063,0.0008291294,0.0005590564,0.0002591904,0.0007536979,0.00342979,0.00002653049,0.002237448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005513262,"threshold_uncertainty_score":0.02915728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02203595424665817,"score_gpt":0.2757516544785674,"score_spread":0.2537157002319093,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}